Antisense oligonucleotide splice-modulation therapy is a promising approach to restoring dystrophin expression in genetic diseases such as muscular dystrophy. Brain
A new article argues that, based on recent behavioral and neuroimaging studies, low doses of psychedelics may provide relief for various mood disorders -- without the typical adverse effects. Medscape Medical News
Oral teriflunomide provided sustained benefits similar to those seen with existing injectable disease-modifying agents in the now-published phase 3 TEMSO study. Medscape Medical News